- Home
- SRRK vs ADT Comparison
SRRK vs ADT Comparison
Compare SRRK & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRRK | ADT |
|---|---|---|
| Founded | 2012 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SRRK | ADT |
|---|---|---|
| Price | $49.35 | $6.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $56.17 | $7.75 |
| AVG Volume (30 Days) | 1.1M | ★ 9.2M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | N/A | ★ 29.63 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,128,607,000.00 |
| Revenue This Year | N/A | $1.90 |
| Revenue Next Year | $534.24 | $2.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.70 |
| 52 Week Low | $27.07 | $6.27 |
| 52 Week High | $52.19 | $8.94 |
Technical Indicators
Market Signals| Indicator | SRRK | ADT |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 40.68 |
| Support Level | $45.46 | $6.27 |
| Resistance Level | $51.55 | $6.74 |
| Average True Range (ATR) | 2.07 | 0.15 |
| MACD | 0.38 | -0.01 |
| Stochastic Oscillator | 92.50 | 27.78 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.